EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
+46.22%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$404M
AUM Growth
+$291M
(+256%)
Cap. Flow
+$221M
Cap. Flow
% of AUM
54.6%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
MiMedx Group
MDXG
|
+$247M |
Top Sells
| 1 |
EyePoint Pharmaceuticals
EYPT
|
+$26.6M |
| 2 |
Venus Concept
VERO
|
+$13 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
MiMedx Group
MDXG
$1.03B
| $247M | 61.19% |
+28,195,249
| New | +$247M |
|
2
Bioventus
BVS
$480M
| $68.6M | 16.98% |
13,021,324
| – | – |
|
|
3
EyePoint Pharmaceuticals
EYPT
$924M
| $54M | 13.37% |
2,337,786
-1,153,135
| -33% | -$26.6M |
|
4
TELA Bio
TELA
$62.6M
| $27.2M | 6.73% |
4,110,709
| – | – |
|
|
RVNC
5
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.02M | 0.99% |
457,085
| – | – |
|
6
MediciNova
MNOV
$60.8M
| $1.66M | 0.41% |
1,105,941
| – | – |
|
|
7
Venus Concept
VERO
$4.24M
| $1.29M | 0.32% |
99,017
-1
| -0% | -$13 |
|